Management of Benzodiazepine Overdose and Sialorrhea

Indications and Contraindications for Flumazenil

The American Heart Association classifies flumazenil as Class 3: Harm in patients with increased risk of seizures 2
Flumazenil is indicated only for reversing benzodiazepine-induced respiratory depression and sedation in selected patients, not for routine use 1
The American Heart Association explicitly recommends not administering flumazenil to patients with undifferentiated coma due to the risk outweighing any potential benefit 3
Flumazenil should be available when benzodiazepines are administered, but its use should be selective and cautious 1

The American College of Chest Physicians recommends starting with an oral anticholinergic agent as first-line therapy for patients with sialorrhea 4, 5, 6
Economic oral anticholinergic medications (glycopyrrolate or sublingual atropine) should be the first step 7
If inadequate, escalate to anticholinergic patches 4
If refractory, consider botulinum toxin 4, 8
In severe cases with significant weakness, consider radiation therapy in experienced centers 4, 8

Serious adverse events (seizures and arrhythmias) occur significantly more frequently with flumazenil compared to supportive care alone 2
Resedation can occur because the effects of flumazenil (1 mg or less) may wear off before the effects of many benzodiazepines 3
Requires continuous monitoring for at least 2 hours after administration 3

Sialorrhea increases the risk of aspiration pneumonia due to impaired airway protection 7
It is common in neuromuscular diseases, particularly ALS, and can be very distressing, reducing quality of life 4, 5, 8